BA
COCH icon

Ballew Advisors’s Envoy Medical COCH Stock Holding History

Ballew Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.61K Hold
10,121
– – ﹤0.01% 129
2026
Q1 		$6.6K Hold
10,121
– – ﹤0.01% 118
2025
Q4 		$6.94K Hold
10,121
– – ﹤0.01% 120
2025
Q3 		$9.29K Buy
+10,121
New +$13.7K 0.01% 122

Other funds holding COCH

AFS
AFG Fiduciary Services Hingham, Massachusetts $128M AUM 24.3% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ballew Advisors's COCH Position: Q2 2026 in Review

Ballew Advisors held its Envoy Medical (COCH) position steady in Q2 2026 at 10,121 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #129.

Ballew Advisors first reported a position in COCH in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.29K in Q3 2025. 5 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Ballew Advisors held 10,121 shares of Envoy Medical worth $7.61K as of Q2 2026.
  • Ballew Advisors left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Ballew Advisors's portfolio in Q2 2026, its #129 holding.
  • Ballew Advisors first reported a position in Envoy Medical in Q3 2025 and has held it in 4 quarters since.
  • Ballew Advisors's Envoy Medical position peaked at $9.29K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Ballew Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.